Synthetic Lethal Screen to Identify Molecular Mechanisms that Drive Uveal Melanoma
Melanoma that strikes the uveal cells of the eye represents about 5% of all melanoma cases. Uveal melanoma is a highly aggressive form of cancer that exhibits a propensity to metastasize to the liver. At this time there are no effective treatments for metastatic uveal melanoma and new therapeutic strategies are urgently needed. The majority of uveal melanomas are derived from early activating mutations in the G-proteins GNA11 or GNAQ. In order to further explore and identify molecular mechanisms that uveal melanoma cell lines rely upon for proliferation and survival, we will perform CRISPR/Cas9 mediated synthetic lethality screening. To accomplish this, we will generate a uveal melanoma cell line 92.1 that expresses the endonuclease Cas9 and introduce a guide RNA library into it that targets the functional domains of epigenetic regulator proteins. Thus, we will be able to determine which epigenetic regulator genes are required for the survival and proliferation of these cells by measuring which guide RNAs "drop out" over time. The guide RNAs that drop out likely disrupt essential genes that the cell relies on for growth. Cells carrying these gRNAs are consequently depleted from the culture. This will indicate that Cas9 mediated disruption of the gene targeted by that guide RNA causes cell death and will therefore identify the key dependencies of the uveal melanoma cells. We expect that the results of these experiments will reveal novel genetic mechanisms characteristic of GNAQ mutant uveal melanoma cells which could be therapeutically targeted in the future.
Damato, B. E., & Coupland, S. E. (2012). Ocular melanoma. Saudi Journal of Ophthalmology. https://doi.org/10.1016/j.sjopt.2012.02.004
Feng, X., Arang, N., Rigiracciolo, D. C., Lee, J. S., Yeerna, H., Wang, Z., … Gutkind, J. S. (2019). A Platform of Synthetic Lethal Gene Interaction Networks Reveals that the GNAQ Uveal Melanoma Oncogene Controls the Hippo Pathway through FAK. Cancer Cell, 1–16. https://doi.org/10.1016/j.ccell.2019.01.009
Meyers, R. M., Bryan, J. G., McFarland, J. M., Weir, B. A., Sizemore, A. E., Xu, H., … Tsherniak, A. (2017). Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells. Nature Genetics. https://doi.org/10.1038/ng.3984
O’Neil, N. J., Bailey, M. L., & Hieter, P. (2017). Synthetic lethality and cancer. Nature Reviews Genetics. https://doi.org/10.1038/nrg.2017.47
Shi, J., Wang, E., Milazzo, J. P., Wang, Z., Kinney, J. B., & Vakoc, C. R. (2015). Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains. Nature Biotechnology, 33(6), 661–667. https://doi.org/10.1038/nbt.3235
Tsherniak, A., Vazquez, F., Montgomery, P. G., Weir, B. A., Kryukov, G., Cowley, G. S., … Hahn, W. C. (2017). Defining a Cancer Dependency Map. Cell. https://doi.org/10.1016/j.cell.2017.06.010
Van Raamsdonk, C. D., Griewank, K. G., Crosby, M. B., Garrido, M. C., Vemula, S., Wiesner, T., … Bastian, B. C. (2010). Mutations in GNA11 in Uveal Melanoma. New England Journal of Medicine. https://doi.org/10.1056/NEJMoa1000584
Wang, T., Birsoy, K., Hughes, N. W., Krupczak, K. M., Post, Y., Wei, J. J., … Sabatini, D. M. (2015). Identification and characterization of essential genes in the human genome. Science. https://doi.org/10.1126/science.aac7041
Copyright (c) 2019 Kristin Lee Recker, Sharon Norton, Amin Sobh, Alberto Riva, Kenneth Chang, Jeffim Kuznetsov, Michael Durante, Fernanda Flores, Richard L Bennett, Christopher Vakoc, Kieran Smalley, William Harbour, Jonathan D Licht
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Some journals stipulate that submitted articles cannot be under consideration for publication or published in another journal. The student-author and mentor have the option of determining which journal the paper will be submitted to first. UF JUR accepts papers that have been published in other journals or might be published in the future. It is the responsibility of the student-author and mentor to determine whether another journal will accept a paper that has been published in UF JUR.